Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Hanley

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLsDan Li, Yufeng Li, Jessica A Hernandez, et al.
Journal of Translational Medicine|September 25, 2019
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralizationAllison B Powell, Sridevi Yadavilli, Devin Saunders, et al.
British Journal of Haematology|June 21, 2019
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapyMichael D Keller, Sam Darko, Haili Lang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2018
HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected IndividualsJulia A Sung, Shabnum Patel, Matthew L Clohosey, et al.
Blood|January 30, 2010
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationKenneth P Micklethwaite, Barbara Savoldo, Patrick J Hanley, et al.
Blood|August 25, 2009
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantationAnn M Leen, Anne Christin, Gary D Myers, et al.
Blood|May 16, 2009
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesPatrick J Hanley, Conrad Russell Young Cruz, Barbara Savoldo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastomaAlexia Ghazi, Aidin Ashoori, Patrick J Hanley, et al.
Blood Advances|December 14, 2022
Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell diseaseHannah Kinoshita, Mamatha Mandava, Mariah Jensen-Wachspress, et al.
Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLsDan Li, Yufeng Li, Jessica A Hernandez, et al.
Journal of Translational Medicine|September 25, 2019
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralizationAllison B Powell, Sridevi Yadavilli, Devin Saunders, et al.
British Journal of Haematology|June 21, 2019
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapyMichael D Keller, Sam Darko, Haili Lang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2018
HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected IndividualsJulia A Sung, Shabnum Patel, Matthew L Clohosey, et al.
Blood|January 30, 2010
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationKenneth P Micklethwaite, Barbara Savoldo, Patrick J Hanley, et al.
Blood|August 25, 2009
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantationAnn M Leen, Anne Christin, Gary D Myers, et al.
Blood|May 16, 2009
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesPatrick J Hanley, Conrad Russell Young Cruz, Barbara Savoldo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastomaAlexia Ghazi, Aidin Ashoori, Patrick J Hanley, et al.
Blood Advances|December 14, 2022
Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell diseaseHannah Kinoshita, Mamatha Mandava, Mariah Jensen-Wachspress, et al.
Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.
Pageof 10